BACKGROUND: Whether a second arterial conduit improves outcomes after multivessel coronary artery bypass grafting remains unclear. Consequently, arterial conduits other than the left internal thoracic artery are seldom used in the United States.
C
oronary artery disease is a leading cause of death in the United States 1 and Europe. 2 When disease is severe, coronary artery bypass grafting (CABG) is more effective than any other therapy. [3] [4] [5] [6] However, the CABG operation is highly varied; surgeons must choose between biologically disparate bypass conduits and the manner in which they are implanted. These choices are not well standardized, and each variation may carry different risks and benefits.
The left internal thoracic artery (ITA) is the optimal conduit; its patency rates are unmatched, and its anatomic location facilitates anastomosis to the left coronary vessels. [7] [8] [9] The most common CABG operation performed worldwide bypasses the left anterior descending coronary artery with the left ITA, and the other coronary arteries with the saphenous vein. 10 However, higher rates of saphenous vein graft failure relative to the left ITA 9 have led surgeons to search for better secondary conduits. The right ITA and radial artery are both promising, but discordant results in single-center observational studies 11, 12 and worry about increased risks of sternal wound infection 13 or early graft failure 14 impede widespread adoption. Guidelines are vague regarding when to use a second arterial conduit, 10, 15 and many believe equipoise exists. Most recently, a randomized trial of single versus bilateral ITA conduits for CABG demonstrated no benefit 5 years after surgery. 16 However, the trial may have been predisposed to a null result because of crossover between treatments, use of radial artery conduits in the control group, and the near-optimal medical management within the trial. A population-level analysis of "real-world" outcomes is needed to help inform guidelines. We conducted a statewide retrospective cohort study to compare the effectiveness of second arterial conduits with that of venous conduits for CABG in California.
METHODS
All data are available for purchase from the California Office of Statewide Health Planning and Development (OSHPD). 17 The authors are not permitted to share the data directly.
Study Design
We examined patients who underwent primary, multivessel CABG in California between January 1, 2006, and July 1, 2011, to evaluate the influence of a second arterial conduit (radial artery or right ITA) on mortality, stroke, myocardial infarction, and repeat revascularization. The California Committee for the Protection of Human Subjects and the institutional review board at Stanford University approved this research. Informed consent was not required. All authors accept responsibility for the accuracy of the analyses.
Study Population and Intervention
Patients were included if they underwent primary, multivessel CABG with the left ITA during the study period. Exclusion criteria were: out-of-state residency, single-vessel coronary artery disease, history of prior CABG, receipt of >2 arterial conduits, and any concomitant cardiac or aortic operation. Patients who received either a radial artery or right ITA graft comprised the experimental (arterial conduit) group; patients who received a left ITA graft with venous conduits for remaining grafts comprised the control (venous conduit) group.
All records were obtained from the California CABG Outcomes Reporting Program (CCORP), a state-maintained and audited, mandatory clinical registry of all patients undergoing CABG at the 126 nonfederal, California-licensed hospitals, and the California OSHPD Patient Discharge, Emergency Department, and Ambulatory Surgery Center data sets. Operative details and baseline characteristics were collected from the CCORP registry. Additional comorbidities were ascertained from prior hospitalizations, or from diagnoses that were coded as present on admission during the index hospitalization (Table I in the online-only Data Supplement).
Outcomes
The primary end point was all-cause mortality. The OSHPD patient discharge database is linked to the California Department of Public Health Death Statistical Master File, 18 the annual state death record which is distinct from the Social
Clinical Perspective
What Is New?
• In this population-level, retrospective cohort study of 59 432 California residents who underwent primary, isolated multivessel coronary artery bypass grafting with the left internal thoracic artery, receipt of a second arterial conduit was associated with lower mortality and adverse cardiovascular events compared with the receipt of a venous conduit.
• The survival benefit associated with the use of a second arterial conduit extended to patients up to 78 years old.
• As a second arterial conduit, the right internal thoracic artery offered no benefit in comparison with the radial artery, but it was associated with an increased risk of sternal wound infection.
What Are the Clinical Implications?
• Current practice recommendations are vague regarding when to use a second arterial conduit, and, in California, surgeons use a second arterial conduit in <10% of isolated coronary artery bypass grafting operations.
• Based on our results, surgeons should lower their threshold for using additional arterial grafts.
• The radial artery may be the preferred second conduit over the right internal thoracic artery and saphenous vein.
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Security Death Index. Longitudinal clinical follow-up was obtained by matching record linkage number and birth year across all encounters. Secondary end points included perioperative mortality (within 30 days of surgery), sternal wound infection, major adverse cardiovascular and cerebrovascular events (MACCE, defined as the composite of stroke, myocardial infarction, and repeat revascularization), and the cumulative incidence of each individual MACCE event. Sternal wound infection was defined as an infected wound with coexisting osteomyelitis, dehiscence, or mediastinitis, or that requiring surgical debridement. 19 Stroke was defined as an incident ischemic or hemorrhagic cerebral event. Myocardial infarction included any subsequent visit for treatment of an incident acute myocardial infarction. Repeat revascularization included any reoperative CABG or percutaneous coronary intervention after the index operation (see Table II 
Statistical Analysis
The study was designed to achieve a power of at least 99% with an α-level of 0.05 to detect a reduction in the hazard of death by 20% over 8 years in second arterial conduit recipients. We hypothesized that the type of arterial conduit (radial artery versus right ITA) would not affect survival, but had at least 80% power with an α-level of 0.025 to detect a survival difference of 20% in this planned subgroup comparison.
We used propensity score matching to limit confounding by indication. Nonparsimonious logistic regression was used to estimate each patient's probability of receiving a second arterial conduit ( Figure I in the online-only Data Supplement). 20 Patients were optimally matched with up to 4 controls per treated subject (Table III in the online-only Data Supplement). Controls were weighted to estimate the average treatment effect on the treated ( Figure II in the onlineonly Data Supplement). 21 Balance between treatment groups was assessed with standardized mean differences, with ≤10% deemed ideal balance, and ≤20% deemed acceptable balance. 22 As a sensitivity analysis, we also tested our primary hypothesis with a matching-based, instrumental variable design 23 (see Methods in the online-only Data Supplement) to try to mitigate unmeasured confounding attributable to unmeasured characteristics (eg, target vessel anatomy and frailty). In brief, we matched similar patients between surgeons who frequently used second arterial conduits with those who did not. Prespecified subgroup analyses included stratification by number of diseased vessels and a direct comparison of radial artery and right ITA grafts. For the latter subgroup comparison, propensity score matching was performed only among recipients of second arterial conduits to estimate the average treatment effect of receiving a right ITA graft.
We estimated the risk difference (RD) in 30-day mortality and sternal wound infection by calculating the difference in the marginal probability of each outcome; 95% confidence intervals (CIs) were obtained with 100 000 bootstrap replicates of the matched sets. Weighted Cox proportional hazards regression with a robust variance estimator was used to compare survival and freedom from MACCE. Additional estimates were obtained after multivariable adjustment for all baseline characteristics, or inclusion of surgeon as a random effect. The restricted mean survival time was calculated as an alternative means of describing the effect of treatment during the study period. 24 As an exploratory analysis, the cumulative incidence of stroke, myocardial infarction, and repeat revascularization after index CABG was compared between treatment groups with death as a competing risk. Subdistribution hazards in the matched population were estimated with the Fine and Gray method. 25 To explore age-dependent effects of a second arterial conduit on survival, a Cox proportional hazards model was fit to the matched study population with the use of an interaction term for age (modeled as a natural spine) and receipt of a second arterial conduit. Standard errors were computed from 1000 bootstrap replicates.
A gamma sensitivity analysis was performed to determine the sensitivity of our results to unmeasured confounding. 26 All tests of treatment effect were 2-tailed with an α-threshold of 0.05. Statistical analyses were performed in R version 3.2.3 (R Foundation); data management was performed with SAS version 9.2 (SAS Institute). Further statistical details are in the online-only Data Supplement.
RESULTS

Patients and Trends in Arterial Conduit Use
Of 93 652 patients who underwent CABG during the study period, 59 432 were eligible for the investigation (Figure 1 ). At baseline, patients who received a second arterial conduit were younger and had fewer comorbidities than recipients of venous conduits (Table 1) . Propensity score matching successfully balanced the baseline characteristics (Table 1 and Table IV in the online-only Data Supplement). Median follow-up time was 5.3 years (interquartile range, 3.8-6.7 years) for recipients of second arterial conduits and 5.2 years (interquartile range, 3.7-6.6 years) for recipients of venous conduits.
Three hundred thirty-nine surgeons performed at least 1 CABG operation across 126 hospitals, and 239 of these surgeons (70.5%) used a second arterial conduit at least once ( Figure 
Mortality
Thirty-day mortality did not differ between second arterial conduit recipients versus venous conduit re- (Figure 2 ). An exploratory analysis of restricted mean survival times demonstrated that survival significantly diverged 4 years after the index surgery (Figure V in the online-only Data Supplement). The benefit associated with a second arterial conduit persisted even after adjusting for baseline covariates and allowing surgeon-specific effects (Table 2 ), but individual surgeons had a near-negligible effect on the baseline hazard of death after CABG. Our instrumental variable analysis corroborated the overall findings: a second arterial conduit did not affect 30-day mortality but was associated with lower midterm mortality (HR, 0.70; 95% CI, 0.62-0.80) and MACCE after CABG (Table 2, Table V A second arterial conduit exhibited similar stratumspecific influences on mortality in patients with 2-vessel or 3-or-more-vessel disease (Figure VII in the onlineonly Data Supplement). When age was examined as a continuous variable, visualization of the interaction between conduit type and age suggested that second arterial conduits were associated with significantly lower mortality in patients up to 78 years of age at the time of surgery (Figure 3 ).
Major Adverse Cardiovascular and Cerebrovascular Events
Risk of MACCE was significantly lower among recipients of second arterial conduits in comparison with recipients of venous conduits (31.0% versus 36.2% at 7 years; HR, 0.80; 95% CI, 0.76-0.84; P<0.001) (Figure 2) , and individual risks of myocardial infarction (HR, 0.78; 95% CI, 0.70-0.87) and repeat revascularization (HR, 0.82; 95% CI, 0.76-0.88) were also lower ( Figure  VIII in the online-only Data Supplement). There was no difference in the cumulative incidence of stroke after CABG between groups (HR, 0.88; 95% CI, 0.77-1.01), or in the incidence of sternal wound infection within 1 year of surgery (arterial 1.38% versus venous 1.44%; RD, -0.06%; 95% CI, -0.41% to 0.31%).
Radial Artery Versus Right ITA Grafts
In a planned subgroup analysis, we compared similar propensity score-matched populations who received a radial artery with those who received a right ITA as a second conduit (Table VI in the online-only Data Supplement). There was no difference in 30-day mortality (right ITA 1.20% versus radial artery 0.62%; RD, 0.58%; 95% CI, -0.04% to 1.27%) or longer-term mortality (right ITA 10.3% versus radial artery 10.7% at 7 years; HR, 1.10; 95% CI, 0.89-1.37; P=0.38) between recipients of radial artery grafts or right ITA grafts (Table 2 and Figure 2) . The cumulative incidence of stroke, myocardial infarction, and repeat revas- Figure IX in the online-only Data Supplement). There was no difference in the composite end point of MACCE in the primary analysis (HR, 1.12; 95% CI, 1.00-1.26), but a significant increase in the risk of MACCE was noted among right ITA recipients after multivariable adjustment and allowing for surgeonspecific effects (Table 2 and Figure 2 ). The risk of a sternal wound infection within 1 year of surgery was also significantly higher in the right ITA group (right ITA 2.29% versus radial artery 1.22%; RD, 1.07%; 95% CI, 0.15-2.07).
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DISCUSSION
The patients with coronary artery disease who benefit most from CABG are well described, but the optimal operation, and, in particular, the conduits that surgeons should use, remain unclear. Although some observational evidence supports the use of second arterial conduits, 11,12 the benefits are uncertain, 16, 27 and evidence supporting the preferential use of the right ITA over the radial artery is even weaker.
10,15,28
The low and declining rate of second arterial conduit use in California suggests that many physicians are concerned that the risks of sternal wound infection 13 and early graft failure 14 outweigh potential benefits. In a population-based examination of CABG operations in California, we found that second arterial conduits were associated with lower mortality than venous conduits, and among second arterial conduits, the radial artery and right ITA affected mortality similarly.
Although our results concur with findings from some single-center observational studies and meta-analyses, 11, 12 they contradict those of the ART trial (Arterial Revascularization Trial) 16 and a recent post hoc analysis of the SYNTAX trial (Synergy between PCI with Taxus and Cardiac Surgery). 27 The ART investigators randomly assigned 3102 patients at 28 centers to receive CABG Values are n (%) or means±SD. In total, 4.1% of patients were missing data for mitral regurgitation, otherwise no variable with >0.2% missingness. If any missing data present, groups were balanced on missingness for each variable.
*The number of patients and proportions presented are weighted due to variable 1:k matching and for estimation of the average treatment effect on the treated. Total number matched: arterial conduit (n=5813); venous conduit (n=17 930). 
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with either single or bilateral ITA grafts, and found no difference in survival or cardiovascular events 5 years after surgery. But crossover was high: >15% of patients randomly assigned to bilateral ITA grafts received a single ITA graft instead, and 22% of patients randomly assigned to receive a single ITA graft also received a radial artery graft, which may perform as well as a second ITA graft, as our study and others suggest. 29 Also, each patient in the ART received near-perfect medical management, which may have reduced the difference in survival between study arms. Together, these factors may have biased the ART toward the null. The post hoc analysis of the SYNTAX trial defined the treatment arm as receipt of either a radial artery or a second ITA graft. 27 However, investigators found no difference in survival or cardiovascular events 5 years after surgery, 27 but this analysis was underpowered and only followed patients for 5 years. In our study, significant differences in survival only started to appear 4 years after surgery. That mortality differences appear earlier in our study than in the ART may suggest that residual confounding influenced our results, but differences in study design may also play a role. In fact, a recent examination of CABG outcomes in British Columbia demonstrated results similar to ours. 30 The vague recommendations that arterial conduits be "considered in appropriate patients" 10 or in those "with reasonable life expectancy" 15 offer little guidance to surgeons. Coupled with contradictory evidence between studies, it is not surprising that arterial conduits are used in <10% of CABG operations in California. The guidelines are based on single-center observational studies and meta-analyses of these studies. 10, 15 However, few studies try to account for confounding by indication, and the single-center design of each study limits statistical power and raises further concern for selection bias and generalizability. Examining outcomes across the state of California, we found that second arterial conduits, in comparison with venous conduits, were associated with lower mortality in patients as old as 78 years. We also observed that mortality differences between groups appeared as early as 4 years after surgery, but 85% to 90% of patients will survive beyond 5 years. 4, 16 Collectively, our data suggest that many patients may be clinically appropriate candidates and have a "reasonable life expectancy"; in other words, second arterial conduits may be grossly underused.
European guidelines recommend the radial artery as a reasonable, although less desirable, alternative to the right ITA as a second conduit. 10, 15 Prior investiga- ORIGINAL RESEARCH ARTICLE tions demonstrate its superiority over saphenous vein grafts, 31 but inferiority to the right ITA. 28 Although radial artery patency is related to target vessel size and stenosis, 14 the only randomized trial comparing radial artery grafts with free right ITA grafts demonstrated no difference in patency, but improved survival among recipients of radial artery grafts. 29 We found a lower incidence of sternal wound infection in recipients of radial artery grafts but no difference in overall survival or individual cardiovascular events. Theoretically, a right ITA graft should perform better when it is pedicled rather than free, but pedicled grafts are shorter and restricted to bypassing proximal lesions. That the effect of a radial artery graft on mortality was no different from a combination of pedicled and free right ITA grafts suggests that the increased versatility of the radial artery may be a side benefit. However, concern that radial artery conduits may be more susceptible to competitive flow may have led to preferential use of radial arteries for grafting lateral wall targets with 
high-grade stenoses, and this may have biased our results. Nevertheless, it is biologically plausible that either artery is better equipped than the saphenous vein to withstand systemic pressures, and coupled with the excess risk of sternal wound infection noted in our study and others, 16 perhaps future guidelines should deemphasize the distinction between radial artery and right ITA grafts.
Coronary bypass with multiple arterial grafts is a more challenging operation, and variability in surgeon experience and hospital resources may produce heterogeneous treatment effects. Professional societies must consider this procedural variability when creating recommendations for specific components of the operation. Although surgeon and hospital volume may influence immediate results, 32 individual surgeons contributed near-negligible effects to the longer-term hazard of death over the study period. This suggests that most surgeons can perform the operation effectively. Across California, 70% of surgeons performed at least 1 CABG operation with a second arterial conduit, and the 20% improvement in the hazard of death afforded by a second arterial conduit that we observed in our study may be more representative of widespread community adoption of such a technique.
This study has several limitations. Propensity score matching cannot account for residual confounding owing to unmeasured variables; and information about medication use, conduit harvest technique (eg, skeletonized versus nonskeletonized), target vessel and conduit size, target vessel stenosis, and graft configuration was not available in CCORP. Therefore, we cannot rule out a systematic bias introduced by more frail patients with less-optimal targets receiving venous conduits. OSHPD does not track patients who leave California, and this can bias our results if emigration rates differed between treatment groups. Last, complications of radial artery harvest were not tracked in the CCORP registry and are difficult to identify with diagnosis codes. To our knowledge, this is the largest study to date that compares outcomes between secondary conduits for CABG, and the real-world examination of conduit types implanted and managed by a broad mix of providers is unique.
In this population-level comparison of secondary conduits, arterial grafts were associated with significantly lower mortality in patients undergoing multivessel CABG in comparison with venous grafts, but a right ITA graft offered no benefit over that of a radial artery. Second arterial conduits were also associated with lower risks of myocardial infarction and repeat revascularization. That a survival benefit arose within 5 years of surgery and even extended to the elderly suggests that surgeons should lower their threshold for using arterial grafts. Although the type of arterial conduit did not influence all-cause mortality, the association with a reduction in the risk of sternal wound infection suggests a radial artery may be the preferred second conduit.
ARTICLE INFORMATION
Received August 5, 2017; accepted November 29, 2017 .
The online-only Data Supplement is available with this article at http://circ. ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.117.030959/-/ DC1.
